PubRank

Hisao Asamura

Author PubWeight™ 159.46‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J Thorac Oncol 2011 21.49
2 The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer. J Thorac Oncol 2009 7.63
3 Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy. Proc Natl Acad Sci U S A 2008 5.18
4 A prospective radiological study of thin-section computed tomography to predict pathological noninvasiveness in peripheral clinical IA lung cancer (Japan Clinical Oncology Group 0201). J Thorac Oncol 2011 2.78
5 Initial analysis of the international association for the study of lung cancer mesothelioma database. J Thorac Oncol 2012 2.57
6 Recommendations for uniform definitions of surgical techniques for malignant pleural mesothelioma: a consensus report of the international association for the study of lung cancer international staging committee and the international mesothelioma interest group. J Thorac Oncol 2011 2.41
7 Comprehensive histologic analysis of ALK-rearranged lung carcinomas. Am J Surg Pathol 2011 2.21
8 Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann Thorac Surg 2006 2.20
9 A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol 2009 2.14
10 Which is the better prognostic factor for resected non-small cell lung cancer: the number of metastatic lymph nodes or the currently used nodal stage classification? J Thorac Oncol 2011 2.03
11 Large cell neuroendocrine carcinoma of the lung: a clinicopathologic study of eighty-seven cases. J Thorac Cardiovasc Surg 2002 1.91
12 "Early" peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann Thorac Surg 2002 1.76
13 Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study. Lung Cancer 2005 1.58
14 Thymoma: a clinicopathologic study based on the new World Health Organization classification. J Thorac Cardiovasc Surg 2003 1.55
15 High-grade lung adenocarcinoma with fetal lung-like morphology: clinicopathologic, immunohistochemical, and molecular analyses of 17 cases. Am J Surg Pathol 2013 1.53
16 Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade. J Thorac Oncol 2011 1.53
17 ROS1-rearranged lung cancer: a clinicopathologic and molecular study of 15 surgical cases. Am J Surg Pathol 2013 1.52
18 Epidermal growth factor receptor mutation status and clinicopathological features of combined small cell carcinoma with adenocarcinoma of the lung. Cancer Sci 2007 1.47
19 The utility of the proposed IASLC/ATS/ERS lung adenocarcinoma subtypes for disease prognosis and correlation of driver gene alterations. Lung Cancer 2013 1.46
20 STAT6 immunohistochemistry is helpful in the diagnosis of solitary fibrous tumors. Am J Surg Pathol 2014 1.41
21 Pulmonary resection in patients aged 80 years or over with clinical stage I non-small cell lung cancer: prognostic factors for overall survival and risk factors for postoperative complications. J Thorac Oncol 2009 1.38
22 Grade of stromal invasion in small adenocarcinoma of the lung: histopathological minimal invasion and prognosis. Am J Surg Pathol 2004 1.36
23 The IASLC Lung Cancer Staging Project: proposals for the inclusion of broncho-pulmonary carcinoid tumors in the forthcoming (seventh) edition of the TNM Classification for Lung Cancer. J Thorac Oncol 2008 1.34
24 Prospective study of the accuracy of EGFR mutational analysis by high-resolution melting analysis in small samples obtained from patients with non-small cell lung cancer. Clin Cancer Res 2008 1.31
25 Inflammatory myofibroblastic tumor of the lung. Eur J Cardiothorac Surg 2004 1.31
26 Bright-field dual-color chromogenic in situ hybridization for diagnosing echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase-positive lung adenocarcinomas. J Thorac Oncol 2011 1.23
27 Pathologic diagnosis of advanced lung cancer based on small biopsies and cytology: a paradigm shift. J Thorac Oncol 2010 1.22
28 The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014 1.21
29 Clinicopathologic features of peripheral squamous cell carcinoma of the lung. Ann Thorac Surg 2004 1.20
30 Lung adenocarcinoma with mixed bronchioloalveolar and invasive components: clinicopathological features, subclassification by extent of invasive foci, and immunohistochemical characterization. Am J Surg Pathol 2003 1.19
31 Visceral pleura invasion impact on non-small cell lung cancer patient survival: its implications for the forthcoming TNM staging based on a large-scale nation-wide database. J Thorac Oncol 2009 1.19
32 Malignant glomus tumor of the lung. Pathol Int 2003 1.18
33 Left pneumonectomy for lung cancer after correction of contralateral partial anomalous pulmonary venous return. Ann Thorac Surg 2005 1.18
34 Phase II trial of preoperative chemoradiotherapy followed by surgical resection in patients with superior sulcus non-small-cell lung cancers: report of Japan Clinical Oncology Group trial 9806. J Clin Oncol 2008 1.16
35 Hypermethylation of the TSLC1/IGSF4 promoter is associated with tobacco smoking and a poor prognosis in primary nonsmall cell lung carcinoma. Cancer 2006 1.15
36 Japanese Lung Cancer Registry Study: first prospective enrollment of a large number of surgical and nonsurgical cases in 2002. J Thorac Oncol 2010 1.13
37 Immunohistochemical detection of GLUT-1 can discriminate between reactive mesothelium and malignant mesothelioma. Mod Pathol 2006 1.12
38 The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the T Component for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014 1.12
39 Minute pulmonary meningothelial-like nodules: clinicopathologic analysis of 121 patients. Hum Pathol 2009 1.11
40 The IASLC lung cancer staging project: the new database to inform the eighth edition of the TNM classification of lung cancer. J Thorac Oncol 2014 1.11
41 Primary mediastinal large B-cell lymphoma: a single-institution clinical study in Japan. Int J Hematol 2004 1.10
42 Multiple lung adenocarcinomas showing ground-glass opacities on thoracic computed tomography. Ann Thorac Surg 2006 1.10
43 The usefulness of mutation-specific antibodies in detecting epidermal growth factor receptor mutations and in predicting response to tyrosine kinase inhibitor therapy in lung adenocarcinoma. Lung Cancer 2010 1.10
44 Promoter methylation of DAL-1/4.1B predicts poor prognosis in non-small cell lung cancer. Clin Cancer Res 2005 1.08
45 Analysis of expression patterns of breast cancer-specific markers (mammaglobin and gross cystic disease fluid protein 15) in lung and pleural tumors. Arch Pathol Lab Med 2008 1.07
46 hASH1 expression is closely correlated with endocrine phenotype and differentiation extent in pulmonary neuroendocrine tumors. Mod Pathol 2004 1.07
47 Combined resection of superior vena cava for lung carcinoma: prognostic significance of patterns of superior vena cava invasion. Ann Thorac Surg 2004 1.06
48 Mutations of the epidermal growth factor receptor gene in atypical adenomatous hyperplasia and bronchioloalveolar carcinoma of the lung. Lung Cancer 2005 1.06
49 Immunohistochemical KIT (CD117) expression in thymic epithelial tumors. Chest 2005 1.06
50 c-MET/phospho-MET protein expression and MET gene copy number in non-small cell lung carcinomas. J Thorac Oncol 2012 1.06
51 Clinical responses of large cell neuroendocrine carcinoma of the lung to cisplatin-based chemotherapy. Lung Cancer 2005 1.06
52 Histological scoring for small lung adenocarcinomas 2 cm or less in diameter: a reliable prognostic indicator. J Thorac Oncol 2010 1.03
53 Recent results of postoperative mortality for surgical resections in lung cancer. Ann Thorac Surg 2004 1.02
54 Surgical outcome of stage IIIA- cN2/pN2 non-small-cell lung cancer patients in Japanese lung cancer registry study in 2004. J Thorac Oncol 2012 1.02
55 Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung. J Thorac Oncol 2011 1.01
56 Aberrant anaplastic lymphoma kinase expression in high-grade pulmonary neuroendocrine carcinoma. J Clin Pathol 2013 1.01
57 The IASLC/ITMIG thymic malignancies staging project: development of a stage classification for thymic malignancies. J Thorac Oncol 2013 1.00
58 Gene expression profiling of epidermal growth factor receptor/KRAS pathway activation in lung adenocarcinoma. Cancer Sci 2007 1.00
59 Prognostic implication of metastasis limited to segmental (level 13) and/or subsegmental (level 14) lymph nodes in patients with surgically resected nonsmall cell lung carcinoma and pathologic N1 lymph node status. Cancer 2012 1.00
60 Clinical statement on the role of the surgeon and surgical issues relating to computed tomography screening programs for lung cancer. Ann Thorac Surg 2013 0.98
61 Development and validation of diagnostic prediction model for solitary pulmonary nodules. Respirology 2007 0.98
62 The IASLC/ITMIG Thymic Epithelial Tumors Staging Project: proposals for the N and M components for the forthcoming (8th) edition of the TNM classification of malignant tumors. J Thorac Oncol 2014 0.98
63 Successful pulmonary resection of lung cancer in a patient with partial anomalous pulmonary venous connection: report of a case. Surg Today 2002 0.96
64 Survival differences by gender for resected non-small cell lung cancer: a retrospective analysis of 12,509 cases in a Japanese Lung Cancer Registry study. J Thorac Oncol 2010 0.96
65 Management of primary malignant germ cell tumor of the mediastinum. Jpn J Clin Oncol 2004 0.95
66 Visceral pleural invasion classification in non-small-cell lung cancer in the 7th edition of the tumor, node, metastasis classification for lung cancer: validation analysis based on a large-scale nationwide database. J Thorac Oncol 2013 0.94
67 Proceedings of the IASLC International Workshop on Advances in Pulmonary Neuroendocrine Tumors 2007. J Thorac Oncol 2008 0.92
68 Array-based comparative genomic hybridization analysis of high-grade neuroendocrine tumors of the lung. Cancer Sci 2005 0.92
69 Surgical Intervention for Non-Small-Cell Lung Cancer Patients with Pleural Carcinomatosis: Results From the Japanese Lung Cancer Registry in 2004. J Thorac Oncol 2015 0.92
70 CT findings of surgically resected large cell neuroendocrine carcinoma of the lung in 38 patients. AJR Am J Roentgenol 2004 0.91
71 Surgery for small cell lung cancer: a retrospective analysis of 243 patients from Japanese Lung Cancer Registry in 2004. J Thorac Oncol 2014 0.90
72 Supplementary prognostic variables for pleural mesothelioma: a report from the IASLC staging committee. J Thorac Oncol 2014 0.90
73 The new strategy of selective nodal dissection for lung cancer based on segment-specific patterns of nodal spread. Interact Cardiovasc Thorac Surg 2005 0.90
74 Superior and basal segment lung cancers in the lower lobe have different lymph node metastatic pathways and prognosis. Ann Thorac Surg 2008 0.89
75 Surgical management of recurrent thymic epithelial tumors: a retrospective analysis based on the Japanese nationwide database. J Thorac Oncol 2015 0.89
76 Clinicopathologic analysis of multiple (five or more) atypical adenomatous hyperplasias (AAHs) of the lung: evidence for the AAH-adenocarcinoma sequence. J Thorac Oncol 2010 0.89
77 Differences in the prognosis of resected lung adenocarcinoma according to the histological subtype: a retrospective analysis of Japanese lung cancer registry data. Eur J Cardiothorac Surg 2013 0.89
78 Mouse model for ROS1-rearranged lung cancer. PLoS One 2013 0.88
79 Divergent cyclin B1 expression and Rb/p16/cyclin D1 pathway aberrations among pulmonary neuroendocrine tumors. Mod Pathol 2004 0.88
80 Successful resection of hepatocellular carcinoma with bronchobiliary fistula caused by repeated transcatheter arterial embolizations: Report of a case. Surg Today 2007 0.88
81 Ciliated muconodular papillary tumors of the lung: a clinicopathologic analysis of 10 cases. Am J Surg Pathol 2015 0.88
82 Hippo pathway gene mutations in malignant mesothelioma: revealed by RNA and targeted exon sequencing. J Thorac Oncol 2015 0.87
83 Lymph node dissection for lung cancer: significance, strategy, and technique. J Thorac Oncol 2009 0.87
84 Prognostic factors for malignant pericardial effusion treated by pericardial drainage in solid-malignancy patients. Med Oncol 2007 0.87
85 Modern surgical results of lung cancer involving neighboring structures: a retrospective analysis of 531 pT3 cases in a Japanese Lung Cancer Registry Study. J Thorac Cardiovasc Surg 2012 0.87
86 Molecular markers and changes of computed tomography appearance in lung adenocarcinoma with ground-glass opacity. Jpn J Clin Oncol 2007 0.86
87 Histologic prognostic factors for small-sized squamous cell carcinomas of the peripheral lung. Lung Cancer 2006 0.86
88 Mucin-producing adenocarcinoma of the lung: thin-section computed tomography findings in 48 patients and their effect on prognosis. J Comput Assist Tomogr 2005 0.86
89 Does the mode of surgical resection affect the prognosis/recurrence in patients with thymoma? J Surg Oncol 2013 0.85
90 Clinicopathological analysis of primary lung carcinoma with heterotopic ossification. Lung Cancer 2008 0.85
91 Improvements in surgical results for lung cancer from 1989 to 1999 in Japan. J Thorac Oncol 2009 0.85
92 Expression of squamous cell carcinoma markers and adenocarcinoma markers in primary pulmonary neuroendocrine carcinomas. Appl Immunohistochem Mol Morphol 2013 0.84
93 [Lung cancer in Japan: analysis of lung cancer registry cases resected in 2004]. Nihon Kokyuki Gakkai Zasshi 2011 0.84
94 Gender difference in survival of resected non-small cell lung cancer: histology-related phenomenon? J Thorac Cardiovasc Surg 2009 0.84
95 Problems in diagnosis and surgical management of clinical N1 non-small cell lung cancer. Ann Thorac Surg 2005 0.84
96 Cytological features of signet-ring cell carcinoma of the lung: comparison with the goblet-cell-type adenocarcinoma of the lung. Diagn Cytopathol 2009 0.84
97 Intrapulmonary lymph nodes: thin-section CT features of 19 nodules. J Comput Assist Tomogr 2002 0.83
98 Immunohistochemical expression of TTF-1 in various cytological subtypes of primary lung adenocarcinoma, with special reference to intratumoral heterogeneity. Pathol Int 2008 0.83
99 Malignant pulmonary epithelioid hemangioendothelioma with hilar lymph node metastasis. Ann Diagn Pathol 2010 0.83
100 Insulin-like growth factor-1 receptor protein expression and gene copy number alterations in non-small cell lung carcinomas. Hum Pathol 2012 0.83
101 Interobserver agreement in the nuclear grading of primary pulmonary adenocarcinoma. J Thorac Oncol 2013 0.82
102 Computed tomographic findings and prognosis in thymic epithelial tumor patients. J Comput Assist Tomogr 2008 0.82
103 Prognostic impact of pleural invasion in 1488 patients with surgically resected non-small cell lung carcinoma. Jpn J Clin Oncol 2013 0.82
104 Carcinoma of donor origin after allogeneic peripheral blood stem cell transplantation. Am J Surg Pathol 2012 0.82
105 Histological evaluation of the effect of smoking on peripheral small adenocarcinomas of the lung. J Thorac Oncol 2008 0.81
106 Early stage lung cancer: progress in the last 40 years.. J Thorac Oncol 2014 0.81
107 The ITMIG/IASLC Thymic Epithelial Tumors Staging Project: A Proposed Lymph Node Map for Thymic Epithelial Tumors in the Forthcoming 8th Edition of the TNM Classification of Malignant Tumors. J Thorac Oncol 2014 0.80
108 The impact of residual tumor morphology on prognosis, recurrence, and fistula formation after lung cancer resection. J Thorac Oncol 2008 0.80
109 Clinicopathological characteristics of screen-detected lung cancers. J Thorac Oncol 2009 0.79
110 A case of pulmonary epithelioid hemangioendothelioma. Jpn J Clin Oncol 2010 0.79
111 Characteristics of loss of heterozygosity in large cell neuroendocrine carcinomas of the lung and small cell lung carcinomas. Pathol Int 2006 0.79
112 Steroid receptor expression in thymomas and thymic carcinomas. Cancer 2011 0.79
113 Identity, similarity, and difference between large cell neuroendocrine carcinoma and small cell carcinoma. J Thorac Oncol 2011 0.78
114 Response: a critique of the international association for the study of lung cancer lymph node map. J Thorac Oncol 2012 0.78
115 A Phase III trial comparing irinotecan and cisplatin with etoposide and cisplatin in adjuvant chemotherapy for completely resected pulmonary high-grade neuroendocrine carcinoma (JCOG1205/1206). Jpn J Clin Oncol 2014 0.78
116 Proteomic study of malignant pleural mesothelioma by laser microdissection and two-dimensional difference gel electrophoresis identified cathepsin D as a novel candidate for a differential diagnosis biomarker. J Proteomics 2011 0.78
117 Surgical treatment of pulmonary metastasis from hepatocellular carcinoma. Hepatogastroenterology 2007 0.78
118 Can image analysis on high-resolution computed tomography predict non-invasive growth in adenocarcinoma of the lung? Ann Thorac Cardiovasc Surg 2014 0.77
119 Treatment of choice for stage I non-small cell lung cancer: surgery or radiotherapy? J Thorac Oncol 2006 0.77
120 Multiple primary cancers or multiple metastases, that is the question. J Thorac Oncol 2010 0.77
121 Results of T4 surgical cases in the Japanese Lung Cancer Registry Study: should mediastinal fat tissue invasion really be included in the T4 category? J Thorac Oncol 2013 0.77
122 Consensus report IASLC workshop Bruges, September 2002: pretreatment minimal staging for non-small cell lung cancer. Lung Cancer 2003 0.76
123 Refining Prognosis in Lung Cancer: A Report on the Quality and Relevance of Clinical Prognostic Tools. J Thorac Oncol 2015 0.76
124 Comparison of different clones (WT49 versus 6F-H2) of WT-1 antibodies for immunohistochemical diagnosis of malignant pleural mesothelioma. Appl Immunohistochem Mol Morphol 2009 0.76
125 [A Japanese lung cancer registry study at 2002]. Nihon Kokyuki Gakkai Zasshi 2010 0.76
126 Cathepsin D as a potential prognostic marker for lung adenocarcinoma. Pathol Res Pract 2012 0.76
127 Correction: Ultra-High-Resolution Computed Tomography of the Lung: Image Quality of a Prototype Scanner. PLoS One 2015 0.75
128 Surgery after induction chemotherapy or chemoradiotherapy for locally advanced lung cancer: a technical challenge. J Thorac Oncol 2011 0.75
129 Clinical application of costal coaptation pins made of hydroxyapatite and poly-L-lactide composite for posterolateral thoracotomy. Eur J Cardiothorac Surg 2008 0.75
130 Pulmonary neuroendocrine tumors with nuclear inclusion. Pathol Res Pract 2013 0.75
131 [Controversies of video-assisted thoracic surgery (VATS)]. Nihon Geka Gakkai Zasshi 2005 0.75
132 [Neuroendocrine tumors of the lung]. Nihon Rinsho 2004 0.75
133 Knowledge of pulmonary neuroendocrine tumors: where are we now? Thorac Surg Clin 2014 0.75
134 [Standard surgical procedures in lung cancer]. Nihon Rinsho 2002 0.75
135 [Pulmonary epithelioid hemangioendothelioma]. Kyobu Geka 2013 0.75